On July 2, 2024, the Delaware Chancery Court in Sciannella v. AstraZeneca dismissed stockholder claims in connection with the $3 billion merger of Viela Bio and Horizon Therapeutics in 2021. The merger was approved by Viela’s...more
On April 11, 2024, the U.S. Department of the Treasury announced a notice of proposed rulemaking that would expand the enforcement authority of the Committee on Foreign Investment in the United States (“CFIUS” or the...more
6/5/2024
/ CFIUS ,
Civil Monetary Penalty ,
Comment Period ,
Cross-Border Transactions ,
Enforcement Authority ,
FIRRMA ,
Foreign Policy ,
National Security ,
Notice of Proposed Rulemaking (NOPR) ,
Regulatory Agenda ,
Rulemaking Process ,
U.S. Treasury
In another impactful decision, the Delaware Court of Chancery in Sjunde AP-Fonden v. Activision Blizzard Inc. again stressed the importance of the statutory text of the DGCL to dismiss claims by the plaintiffs alleging that...more
The Delaware Court of Chancery decided two cases recently that may have a significant impact on future corporate action, in each stressing the need for corporate actors to follow statutory requirements, even when in potential...more